Lifevantage (NASDAQ:LFVN) Stock Price Crosses Below Two Hundred Day Moving Average - Here's Why

Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $15.71 and traded as low as $11.86. Lifevantage shares last traded at $12.38, with a volume of 206,585 shares changing hands.

Lifevantage Stock Performance

The company has a market cap of $159.14 million, a price-to-earnings ratio of 18.32 and a beta of 0.43. The firm has a fifty day moving average price of $12.71 and a 200 day moving average price of $15.67.

Lifevantage (NASDAQ:LFVN - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.10. Lifevantage had a return on equity of 34.67% and a net margin of 4.12%. The business had revenue of $58.44 million for the quarter, compared to analysts' expectations of $60.99 million.

Lifevantage Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 30th were paid a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date was Friday, May 30th. This is a boost from Lifevantage's previous quarterly dividend of $0.04. Lifevantage's dividend payout ratio is 26.09%.

Insiders Place Their Bets

In related news, CFO Carl Aure sold 2,746 shares of the stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $13.39, for a total value of $36,768.94. Following the sale, the chief financial officer owned 133,303 shares in the company, valued at approximately $1,784,927.17. This represents a 2.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 20.65% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Farther Finance Advisors LLC bought a new position in Lifevantage during the 2nd quarter worth $25,000. Cubist Systematic Strategies LLC bought a new position in Lifevantage during the 1st quarter worth $97,000. Brown Advisory Inc. bought a new position in Lifevantage during the 1st quarter worth $150,000. Cannon Global Investment Management LLC bought a new position in Lifevantage during the 1st quarter worth $156,000. Finally, State of Wyoming bought a new position in Lifevantage during the 1st quarter worth $173,000. Institutional investors own 35.32% of the company's stock.

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.